Cediranib – m-entrepreneurship.com

Product Name :
Cediranib

Search keywords :
Cediranib

drugId :
null

Target Vo:
Vascular endothelial growth factor receptor 1

Target Vo Short Name :
VEGFR1

Moa_Name:
Vascular endothelial growth factor receptor 3 antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Astrazeneca Plc

Active Company_Name :
Astrazeneca Plc

Active Indication_Name:
Ovarian Neoplasms

In Active Indication_Name:
Burkitt Lymphoma

Termination Status :

China Termination Status :
Phase 3 Clinical

Highest Status:
Phase 3 Clinical

China Highest Status:
Pending

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
FOXO4 Antibody
IKK alpha Antibody
eNOS Antibody: eNOS Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 133 kDa, targeting to eNOS. It can be used for WB,IHC-F,IHC-P,ICC/IF,ELISA assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts